135 results
Page 4 of 7
8-K
EX-2.1
v14t ah6qr9t1e6
7 May 21
Entry into a Material Definitive Agreement
7:09am
8-K
EX-10.1
ramjgxv3zsroy
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-2.1
5mapnbfa x1
7 May 21
Business combination disclosure
7:08am
425
EX-10.1
frje27r6u62j7lgd1
7 May 21
Business combination disclosure
7:08am
8-K
EX-3.1
g19q885i6tz01tovl
2 Oct 20
Amendments to Articles of Incorporation or Bylaws
3:39pm
8-K
EX-99.1
ps1op0xn
11 Sep 20
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
7:00am
DEFA14A
4g3kvjpb
11 Sep 20
Additional proxy soliciting materials
7:00am
DEF 14A
34tsqv4whk
9 Sep 20
Definitive proxy
4:00pm
PRE 14A
f5fm9xon1xksgfyy
10 Aug 20
Preliminary proxy
12:00am
424B5
xcspd62 h20q
7 Jul 20
Prospectus supplement for primary offering
4:32pm
10-K
c0l20pcmbq
29 Jun 20
Annual report
4:02pm
10-K
EX-10.3
4m2dby um8touuva
29 Jun 20
Annual report
4:02pm
10-K
EX-10.2
oeyqz4p
29 Jun 20
Annual report
4:02pm
S-3
EX-1.2
tkgpghhj2wxtb 1lwc
29 Jun 20
Shelf registration
12:00am
S-3
k88jdgc45 zgk71
29 Jun 20
Shelf registration
12:00am
6-K
EX-99.1
kqeimz18qwz3
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.2
pvu11s2 sud
14 Feb 20
Current report (foreign)
8:00am
6-K
EX-99.1
8yc2g6y0ycy56 ke7j
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
EX-99.1
z0crhc jt
13 Nov 19
Current report (foreign)
7:55am